Microbot Medical Inc. is a pre-commercial stage medical technology company. It has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. It specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
企業コードMBOT
会社名Microbot Medical Inc
上場日Mar 25, 1992
最高経営責任者「CEO」Gadot (Harel)
従業員数21
証券種類Ordinary Share
決算期末Mar 25
本社所在地175 Derby St Bld 27
都市HINGHAM
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号02043
電話番号17818753605
ウェブサイトhttp://www.microbotmedical.com/
企業コードMBOT
上場日Mar 25, 1992
最高経営責任者「CEO」Gadot (Harel)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし